Here, we present a ligand-based proximity labeling approach to interrogate the native cell membrane interactome for the GLP-1 receptor after agonist simulation
With the right support, participants are more likely to avoid side effects, low engagement, and disappointing outcomes
The co-lyophilised format ensures reproducible fixed-ratio compound delivery across experimental replicates
Figure 2 Further analysis of suicidal ideation or attempts at 3, 6, and 12 months revealed adjusted hazard ratios of 0.04 (95% CI: 0.020.08), 0.07 (95% CI: 0.040.13), and 0.12 (95% CI: 0.080.20), respectively, demonstrating a consistent reduction in risk over time in the tirzepatide group compared to the control group ( Table 2 )
The bottom line: Are they worth it